Veracyte CEO has 8,782 shares withheld for tax

Veracyte’s CEO had shares withheld to cover RSU tax obligations and now directly holds 432,073 VCYT shares.

Rhea-AI Filing Summary

VERACYTE, INC. (VCYT) reported that Chief Executive Officer and director Marc Stapley had 8,782 shares of common stock withheld on September 2, 2026 to satisfy tax withholding obligations related to vesting restricted stock units; this is reported as a disposition but is explicitly described as not representing a sale.

Following this withholding, he directly holds 432,073 shares of Veracyte common stock, which includes 361 shares purchased on July 31, 2026 under the Veracyte, Inc. Employee Stock Purchase Plan. No Rule 10b5-1 trading plan is indicated for this tax-withholding transaction.

Insider Trade Summary

Tax Withholding: 8,782 shares

Tax Withholding 1 txn

Insider Stapley Marc

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F1, F2	8,782	$44.88	$394K

Holdings After Transaction: Common Stock — 432,073 shares (Direct)

Footnotes (2)

1. F1. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and does not represent a sale.
2. F2. Includes 361 shares of common stock purchased on July 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.

Key Figures

Shares withheld for tax: 8,782 shares Per-share value for withholding: $44.88 per share Holdings after transaction: 432,073 shares +1 more

4 metrics

Shares withheld for tax 8,782 shares Shares of Veracyte common stock withheld on September 2, 2026 for tax obligations tied to RSU vesting

Per-share value for withholding $44.88 per share Reported price per share for the 8,782 Veracyte shares withheld on September 2, 2026

Holdings after transaction 432,073 shares Direct Veracyte common stock holdings by CEO Marc Stapley after the September 2, 2026 withholding

ESPP shares included in holdings 361 shares Common shares purchased on July 31, 2026 under the Veracyte, Inc. Employee Stock Purchase Plan included in post-transaction holdings

Key Terms

restricted stock units, tax withholding obligations, Employee Stock Purchase Plan, beneficial ownership

4 terms

restricted stock units financial

"in connection with the vesting of certain restricted stock units on September 2, 2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"withheld to satisfy the Reporting Person's tax withholding obligations in connection"

Employee Stock Purchase Plan financial

"purchased on July 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan"

An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.

beneficial ownership financial

"Includes 361 shares of common stock purchased on July 31, 2026 pursuant"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

What insider transaction did Veracyte (VCYT) report for CEO Marc Stapley?

Veracyte reported that CEO Marc Stapley had 8,782 shares of common stock withheld on September 2, 2026 to satisfy tax withholding obligations from vesting restricted stock units; the filing states this does not represent a sale of shares.

How many Veracyte (VCYT) shares does CEO Marc Stapley hold after this Form 4?

After the September 2, 2026 tax-withholding event, Marc Stapley directly holds 432,073 shares of Veracyte common stock. This total includes 361 shares acquired on July 31, 2026 through the Veracyte, Inc. Employee Stock Purchase Plan.

Was the September 2, 2026 Veracyte (VCYT) insider transaction a market sale?

No. The Form 4 states the 8,782 shares were withheld to satisfy tax withholding obligations upon RSU vesting and explicitly notes that the withholding does not represent a sale of shares on the open market.

What was the reported value per share for the Veracyte (VCYT) tax-withholding event?

The Form 4 reports a value of $44.88 per share for the 8,782 Veracyte common shares withheld on September 2, 2026 in connection with the CEO’s tax withholding obligations related to vesting restricted stock units.

Was Veracyte (VCYT) CEO Marc Stapley’s September 2026 transaction under a Rule 10b5-1 plan?

The filing’s Rule 10b5-1 checkbox is not marked, and the footnotes do not reference any trading plan, so the September 2, 2026 tax-withholding disposition is not reported as occurring under a Rule 10b5-1 plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/04/2026 - 07:54 PM Accepted by SEC EDGAR 09/04/2026 - 07:53 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Stapley Marc

(Last) (First) (Middle)

6000 SHORELINE COURT

SUITE 300

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VERACYTE, INC. [ VCYT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/02/2026		F(1)		8,782	D	$44.88	432,073(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and does not represent a sale.

2. Includes 361 shares of common stock purchased on July 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.

Remarks:

	/s/ Jonathan Wygant, as attorney-in-fact	09/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)